Log in

Company updateMoneycontrol

ICICI Securities retains Buy on Alkem with Rs 6600 target

Positive+19

GreyOak summary

ICICI Securities maintained a Buy rating on Alkem Laboratories with a target price of Rs 6,600. The broker cut FY27-28E EPS estimates by 1-4% due to the Occlutech acquisition impact. Management guided for 11% India growth in FY27 despite margin pressure from the acquisition.

What it affects

Source

Read the original at Moneycontrol

More Alkem Laboratories news

All Alkem Laboratories news →

We use cookies

Essential cookies keep GreyOak secure and functional. Optional cookies help improve your experience and platform performance. You can update your preferences anytime.

Cookie Policy